Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arun Chandrasekharan
Observed names:
A Chandrasekharan,
A. Chandrasekharan,
Arun Chandrashekharan
Institutions:
Malabar Institute of Medical Sciences,
Homi Bhabha National Institute,
Tata Memorial Hospital
Observed institutions:
Malabar Institute of Medical Sciences,
Homi Bhabha National Institute,
Tata Memorial Hospital,
Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital,
Post Graduate Institute of Medical Education and Research
ORCID:
0000-0001-5373-0558
Observed ORCID:
0000-0001-5373-0558
OpenAlex ID:
A5011252737
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
2017
·
Vanita Noronha
, Amit Joshi
, et al.
·
Journal of Clinical Oncology
·
356
Impact of COVID-19 on cancer care in India: a cohort study
2021
·
Priya Ranganathan
, Manju Sengar
, et al.
·
The Lancet Oncology
·
163
PDF
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
2019
·
Vijay Maruti Patil
, Vanita Noronha
, et al.
·
Cancer
·
142
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial
2020
·
Vijay Patil
, Vanita Noronha
, et al.
·
The Lancet Global Health
·
111
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer
2019
·
Vijay M. Patil
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
·
82
Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
2017
·
Vijay Maruti Patil
, Vanita Noronha
, et al.
·
ESMO Open
·
71
PDF
“Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia”
2019
·
J. Bajpai
, S. Kagwade
, et al.
·
The Breast
·
63
Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen ‘OGS-12’
2017
·
Jyoti Bajpai
, Arun Chandrasekharan
, et al.
·
European Journal of Cancer
·
55
Salvage surgery in head and neck cancer: Does it improve outcomes?
2020
·
Vijay Maruti Patil
, Vanita Noronha
, et al.
·
European Journal of Surgical Oncology
·
39
Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial
2022
·
Vijay M. Patil
, Nandini Menon
, et al.
·
EClinicalMedicine
·
26
Expectations and preferences for palliative chemotherapy in head and neck cancers patients
2016
·
Vijay Patil
, Amit Joshi
, et al.
·
Oral Oncology
·
26
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
2020
·
Vanita Noronha
, Vijay Maruti Patil
, et al.
·
Oncotarget
·
25
PDF
Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer.
2017
·
Vanita Noronha
, Amit Joshi
, et al.
·
Journal of Clinical Oncology
·
25
Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach
2018
·
Vijay Patil
, Vanita Noronha
, et al.
·
Journal of Global Oncology
·
21
PDF
Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non–High-Dose Methotrexate–Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center
2018
·
Jyoti Bajpai
, Arun Chandrasekharan
, et al.
·
Journal of Global Oncology
·
20
Osteosarcoma journey over two decades in India: Small steps, big changes
2019
·
Jyoti Bajpai
, Arun Chandrasekharan
, et al.
·
Pediatric Blood & Cancer
·
16
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer
2017
·
Amit Joshi
, Vijay Patil
, et al.
·
Oral Oncology
·
15
Adolescent–adult nonmetastatic Ewing sarcoma—Experience from a large developing country
2021
·
Jyoti Bajpai
, Goutam Santosh Panda
, et al.
·
Pediatric Blood & Cancer
·
14
PDF
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients
2018
·
Vijay Patil
, Amit Joshi
, et al.
·
South Asian Journal of Cancer
·
14
PDF
Comparison of paclitaxel-cetuximab chemotherapy versus metronomic chemotherapy consisting of methotrexate and celecoxib as palliative chemotherapy in head and neck cancers
2017
·
VM Patil
, V Noronha
, et al.
·
Indian Journal of Cancer
·
13
Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income country
2022
·
Goutam Panda
, Arun Chandrasekharan
, et al.
·
ecancermedicalscience
·
12
PDF
Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India
2021
·
Jyoti Bajpai
, George Abraham
, et al.
·
Frontiers in Oncology
·
11
A tale of two patients
2020
·
Arun Chandrasekharan
·
Cancer Research Statistics and Treatment
·
11
Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy
2018
·
Vijay M Patil
, Nikhil Pande
, et al.
·
CNS Oncology
·
11
PDF
Prevalence and types of cancer in older Indians: A multicentric observational study across 17 institutions in India
2024
·
Vanita Noronha
, Abhijith Rajaram Rao
, et al.
·
Cancer Epidemiology
·
9
Show more works
View as search
Works count:
94
Citation count:
1,511
H-index:
16
I10-index:
24
Year
Topic
Type